Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative

Bryce B. Reeve, Molly McFatrich, Laura C. Pinheiro, Meaghann S. Weaver, Lillian Sung, Janice S. Withycombe, Justin N. Baker, Jennifer W. Mack, Mia K. Waldron, Deborah Gibson, Deborah Tomlinson, David R. Freyer, Catriona Mowbray, Shana Jacobs, Diana Palma, Christa E. Martens, Stuart H. Gold, Kathryn D. Jackson, Pamela S. Hinds

Research output: Contribution to journalArticle

  • 7 Citations

Abstract

Background: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. Procedure: From seven pediatric research hospitals, children/adolescents ages 7–15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7–8, 9–12, and 13–15 years. The children/adolescents and proxies were interviewed independently. Results: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as “very easy” or “somewhat easy” and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand. Conclusions: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.

LanguageEnglish (US)
Article numbere26261
JournalPediatric Blood and Cancer
Volume64
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Terminology
Proxy
Interviews
Pediatrics
Patient Reported Outcome Measures
Pediatric Hospitals
Quality of Health Care
Self Report
Age Groups
Clinical Trials
Research

Keywords

  • adverse events
  • cancer
  • cognitive interviews
  • patient-reported outcomes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Eliciting the child's voice in adverse event reporting in oncology trials : Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative. / Reeve, Bryce B.; McFatrich, Molly; Pinheiro, Laura C.; Weaver, Meaghann S.; Sung, Lillian; Withycombe, Janice S.; Baker, Justin N.; Mack, Jennifer W.; Waldron, Mia K.; Gibson, Deborah; Tomlinson, Deborah; Freyer, David R.; Mowbray, Catriona; Jacobs, Shana; Palma, Diana; Martens, Christa E.; Gold, Stuart H.; Jackson, Kathryn D.; Hinds, Pamela S.

In: Pediatric Blood and Cancer, Vol. 64, No. 3, e26261, 01.03.2017.

Research output: Contribution to journalArticle

Reeve, BB, McFatrich, M, Pinheiro, LC, Weaver, MS, Sung, L, Withycombe, JS, Baker, JN, Mack, JW, Waldron, MK, Gibson, D, Tomlinson, D, Freyer, DR, Mowbray, C, Jacobs, S, Palma, D, Martens, CE, Gold, SH, Jackson, KD & Hinds, PS 2017, 'Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative' Pediatric Blood and Cancer, vol 64, no. 3, e26261. DOI: 10.1002/pbc.26261
Reeve, Bryce B. ; McFatrich, Molly ; Pinheiro, Laura C. ; Weaver, Meaghann S. ; Sung, Lillian ; Withycombe, Janice S. ; Baker, Justin N. ; Mack, Jennifer W. ; Waldron, Mia K. ; Gibson, Deborah ; Tomlinson, Deborah ; Freyer, David R. ; Mowbray, Catriona ; Jacobs, Shana ; Palma, Diana ; Martens, Christa E. ; Gold, Stuart H. ; Jackson, Kathryn D. ; Hinds, Pamela S./ Eliciting the child's voice in adverse event reporting in oncology trials : Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative. In: Pediatric Blood and Cancer. 2017 ; Vol. 64, No. 3.
@article{654671612d7c49a9a5898fbe768f2f56,
title = "Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative",
abstract = "Background: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. Procedure: From seven pediatric research hospitals, children/adolescents ages 7–15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7–8, 9–12, and 13–15 years. The children/adolescents and proxies were interviewed independently. Results: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as “very easy” or “somewhat easy” and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand. Conclusions: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.",
keywords = "adverse events, cancer, cognitive interviews, patient-reported outcomes",
author = "Reeve, {Bryce B.} and Molly McFatrich and Pinheiro, {Laura C.} and Weaver, {Meaghann S.} and Lillian Sung and Withycombe, {Janice S.} and Baker, {Justin N.} and Mack, {Jennifer W.} and Waldron, {Mia K.} and Deborah Gibson and Deborah Tomlinson and Freyer, {David R.} and Catriona Mowbray and Shana Jacobs and Diana Palma and Martens, {Christa E.} and Gold, {Stuart H.} and Jackson, {Kathryn D.} and Hinds, {Pamela S.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/pbc.26261",
language = "English (US)",
volume = "64",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Eliciting the child's voice in adverse event reporting in oncology trials

T2 - Pediatric Blood and Cancer

AU - Reeve,Bryce B.

AU - McFatrich,Molly

AU - Pinheiro,Laura C.

AU - Weaver,Meaghann S.

AU - Sung,Lillian

AU - Withycombe,Janice S.

AU - Baker,Justin N.

AU - Mack,Jennifer W.

AU - Waldron,Mia K.

AU - Gibson,Deborah

AU - Tomlinson,Deborah

AU - Freyer,David R.

AU - Mowbray,Catriona

AU - Jacobs,Shana

AU - Palma,Diana

AU - Martens,Christa E.

AU - Gold,Stuart H.

AU - Jackson,Kathryn D.

AU - Hinds,Pamela S.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. Procedure: From seven pediatric research hospitals, children/adolescents ages 7–15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7–8, 9–12, and 13–15 years. The children/adolescents and proxies were interviewed independently. Results: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as “very easy” or “somewhat easy” and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand. Conclusions: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.

AB - Background: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. Procedure: From seven pediatric research hospitals, children/adolescents ages 7–15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7–8, 9–12, and 13–15 years. The children/adolescents and proxies were interviewed independently. Results: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as “very easy” or “somewhat easy” and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand. Conclusions: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.

KW - adverse events

KW - cancer

KW - cognitive interviews

KW - patient-reported outcomes

UR - http://www.scopus.com/inward/record.url?scp=84988443542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988443542&partnerID=8YFLogxK

U2 - 10.1002/pbc.26261

DO - 10.1002/pbc.26261

M3 - Article

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

M1 - e26261

ER -